Monitoring Value of Serum HER2 as a Predictive Biomarker in Patients with Metastatic Breast Cancer.

Pengyu Zhang Jun XiaoYingxin RuanZhenzhen ZhangXuejun Zhang

Published in: Cancer management and research (2020)

Serum HER2 levels in breast cancer patients can partly reflect tissue HER2 expression and tumor imaging changes, and serum HER2 may be used as a biomarker for evaluating metastatic status in patients with breast cancer.

Keyphrases

metastatic breast cancer
squamous cell carcinoma
small cell lung cancer
mass spectrometry
binding protein